Illumina MiSeqDx

This Illumina MiSeqDx is a used FDA-regulated benchtop sequencing platform built for clinical diagnostic use as well as research applications requiring validated, reproducible sequencing output. It combines sequencing-by-synthesis chemistry with an integrated workflow covering library preparation through data analysis, making it suitable for laboratories running molecular diagnostic assays such as cystic fibrosis genotyping or other regulatory-cleared panels. The system's dual regulatory status, supporting both IVD and research use modes, gives labs flexibility as their testing needs evolve. The MiSeqDx delivers reliable short-read sequencing data with onboard analysis software that streamlines base calling, alignment, and variant reporting. It is commonly used in clinical genetics labs, pathology departments, and research institutions that need dependable, well-documented performance for both patient-facing assays and translational research projects. Its compact bench presence and simplified reagent handling reduce the operational burden compared to larger sequencing platforms. Offered here as a used, previously validated unit, this MiSeqDx is a strong option for laboratories seeking to add or expand molecular diagnostic sequencing capacity at a lower capital cost than new equipment. It suits hospital labs, reference laboratories, and academic clinical research groups that need a proven, widely supported sequencing platform. As with any regulated instrument changing hands, buyers should plan for appropriate installation qualification and calibration checks before returning the system to diagnostic service.